As a primary end point, this study focused on the metachronousoccurrence of PC as the sole location of tumor recurrence in colon cancer.The secondary end point was the calculation of a power analysis if onewould aim to start a prospective randomized trial to prove the impact ofadjuvant HIPEC on T4a colon cancer.